Cargando…
Appropriate and inappropriate therapies in remotely monitored patients with cardiac implantable devices long-term experiences of a tertiary centre
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The evidence supporting the implantation of implantable cardioverter-defibrillator (ICD) in the primary prevention of sudden cardiac death (SCD) comes mostly from the times when optimal management of heart failure was not as effect...
Autores principales: | Dyrbus, M, Pyka, L, Kurek, A, Niedziela, J T, Adamowicz, E, Ostrega, M, Sokola, K, Pres, D, Gasior, M, Tajstra, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207611/ http://dx.doi.org/10.1093/europace/euad122.477 |
Ejemplares similares
-
Reorganizing the device clinic: remote monitoring-only of cardiac implantable electronic devices during the Covid-19 pandemic
por: Ebrille, E, et al.
Publicado: (2023) -
The tip of the eventberg: incidental rhythm disturbances by remote monitoring following pulmonary vein isolation
por: Schlogl, S, et al.
Publicado: (2023) -
Impact of the Covid19 pandemic on implantable cardiac device implants in Spain. Data from the nationwide Covid 19 RM (remote monitoring) Spain registry
por: Garcia-Fernandez, F J, et al.
Publicado: (2023) -
Value of implant-based telemonitoring in the high-risk population of ventricular assist device patients
por: Guckel, D, et al.
Publicado: (2023) -
Prediction of all-cause mortality using a multisensor implantable defibrillator algorithm for HF monitoring
por: D'onofrio, A, et al.
Publicado: (2023)